139 related articles for article (PubMed ID: 37286457)
1. Re: First-in-Human Study of the Radioligand
Klümper N; Eckstein M; Hölzel M; Herrmann K; Hadaschik B; Grünwald V
Eur Urol; 2023 Nov; 84(5):514-515. PubMed ID: 37286457
[No Abstract] [Full Text] [Related]
2. First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma.
Duan X; Xia L; Zhang Z; Ren Y; Pomper MG; Rowe SP; Li X; Li N; Zhang N; Zhu H; Yang Z; Sheng X; Yang X
Clin Cancer Res; 2023 Sep; 29(17):3395-3407. PubMed ID: 37093191
[TBL] [Abstract][Full Text] [Related]
3. NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime?
Filippi L; Schillaci O
Expert Rev Anticancer Ther; 2024; 24(1-2):1-4. PubMed ID: 37994866
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Nectin-4: A Promising Tool for Personalized/Precision Oncology.
Jiang D; Lan X; Cai W
Clin Cancer Res; 2023 Sep; 29(17):3259-3261. PubMed ID: 37417960
[TBL] [Abstract][Full Text] [Related]
5. Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with
Zhang J; Duan X; Chen X; Zhang Z; Sun H; Shou J; Zhao G; Wang J; Ma Y; Yang Y; Tian X; Shen Q; Yu W; He Z; Fan Y; Yang X
J Nucl Med; 2024 May; 65(Suppl 1):12S-18S. PubMed ID: 38719240
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of [
Unterrainer LM; Lindner S; Eismann L; Casuscelli J; Gildehaus FJ; Bui VN; Albert NL; Holzgreve A; Beyer L; Todica A; Brendel M; Cyran CC; Karl A; Stief CG; Ledderose ST; Unterrainer M; Bartenstein P; Wenter V; Kretschmer A
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3571-3580. PubMed ID: 35325283
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
[TBL] [Abstract][Full Text] [Related]
8. Urothelial cancer of the uretero-vesical junction on
Parra LA; Stanton ML; Nguyen BD
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(3):180-181. PubMed ID: 31928921
[No Abstract] [Full Text] [Related]
9. Prostate-Specific Membrane Antigen-Avid Bone Metastases From Urothelial Carcinoma of the Bladder.
Zhao B; Dong A; Zuo C
Clin Nucl Med; 2022 Oct; 47(10):892-894. PubMed ID: 35439183
[TBL] [Abstract][Full Text] [Related]
10.
Al-Zubaidi M; Viswambaram P; McCombie S; Liow E; Lenzo N; Ferguson T; Redfern AD; Gauci R; Hayne D
BMJ Open; 2022 Apr; 12(4):e060478. PubMed ID: 35428649
[TBL] [Abstract][Full Text] [Related]
11. [THE USEFULNESS OF POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF METASTASIS IN PATIENTS WITH UROTHELIAL CARCINOMA].
Takayanagi A; Takahashi A; Yorozuya W; Okabe K; Kaji T; Takagi Y
Nihon Hinyokika Gakkai Zasshi; 2022; 113(2):51-55. PubMed ID: 37081652
[TBL] [Abstract][Full Text] [Related]
12. Invasive urothelial carcinoma detected in bladder diverticulum with FDG PET/CT: a rare case with negative cystoscopy.
Ozguven S; Maleki R; Ones T; Inanir S; Erdil TY; Turoglu HT
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):399-400. PubMed ID: 24703992
[No Abstract] [Full Text] [Related]
13. [
Kollberg P; Almquist H; Bläckberg M; Cwikiel M; Gudjonsson S; Lyttkens K; Patschan O; Liedberg F
Scand J Urol; 2017 Aug; 51(4):308-313. PubMed ID: 28532260
[TBL] [Abstract][Full Text] [Related]
14. An iodine‑labelled Antibody-drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma.
Ren Y; Liu T; Li S; Ma X; Xia L; Wang P; Guo Q; Yao Y; Hou X; Sheng X; Zhu H; Yang Z
Int J Pharm; 2024 Feb; 651():123756. PubMed ID: 38160990
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of PET/CT 18-FDG for the diagnosis and follow-up of urological, urothelial and kidney tumours.
González-Ruiz de León C; García-Rodríguez J; Pérez-Castro N; Vigil-Díaz C; Pérez-Haro ML; Fernández-Gómez JM
Actas Urol Esp (Engl Ed); 2019; 43(1):32-38. PubMed ID: 30100141
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head Intra-individual Comparison of [
Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
[TBL] [Abstract][Full Text] [Related]
17. Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma.
Giannatempo P; Alessi A; Miceli R; Raggi D; Farè E; Nicolai N; Serafini G; Padovano B; Piva L; Biasoni D; Torelli T; Catanzaro M; Stagni S; Maffezzini M; Mariani L; Gianni AM; Sonpavde G; Salvioni R; Necchi A; Crippa F
Clin Genitourin Cancer; 2014 Dec; 12(6):433-9. PubMed ID: 24787972
[TBL] [Abstract][Full Text] [Related]
18. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT Findings of Metastasis to Spongy Body of Penis From Urothelial Carcinoma of Bladder.
Wang YL; Fang N; Zeng L; Wu ZJ; Cui XJ
Clin Nucl Med; 2016 May; 41(5):e251-2. PubMed ID: 26359570
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of
Civelek AC; Niglio SA; Malayeri AA; Lin J; Gurram S; Chalfin HJ; Turkbey B; Valera V; Steinberg SM; Apolo AB
Urol Oncol; 2021 Nov; 39(11):787.e17-787.e21. PubMed ID: 34140245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
